反応式
[C:1]([O:4][C:5]1[CH:6]=[C:7]([CH:13]=[CH:14][C:15]=1[O:16][C:17](=[O:19])[CH3:18])[CH:8]=[CH:9][C:10]([OH:12])=O)(=[O:3])[CH3:2].C(O)(=O)/C=[CH:22]/[C:23]1[CH:30]=[CH:29][C:27](O)=[C:25](O)[CH:24]=1.P(Cl)(OCC)(OCC)=O.[Cl-].C([N:45](CC)CC)C>CN(C)C1C=CN=CC=1.C(Cl)Cl>[CH3:22][C@H:23]1[CH2:30][CH2:29][C@H:27]([NH:45][C:10](=[O:12])[CH:9]=[CH:8][C:7]2[CH:13]=[CH:14][C:15]([O:16][C:17](=[O:19])[CH3:18])=[C:5]([O:4][C:1](=[O:3])[CH3:2])[CH:6]=2)[CH2:25][CH2:24]1参加物
8
実験手順
Using 3.4 g of 3,4-diacetoxycinnamic acid derived from caffeic acid by the acetylation thereof, 2.8 ml of diethyl chlorophosphate, 3.9 ml of triethylamine, 2 g of trans-4-methylcyclohexylammmonium chloride, 60 ml of methylene chloride, and 0.6 g of 4-dimethylaminopyridine, a reaction similar to that conducted in Example 81 was carried out. The product obtained was recrystallized from methylene chloride/hexane, yielding 3.19 g of N-(trans-4-methylcyclohexyl)-3,4-diacetoxycinnamamide (a compound of the present invention) as white crystal, which had the following physiochemical properties:
後処理
- customThe product obtained
- customwas recrystallized from methylene chloride/hexane
出典と根拠
- ORDレコード
- ord-7b88b2ba4e274b3aaba3547fb5951e4c
- 出典データセット
- uspto-grants-1994_09
- 特許番号
- US05344845
関連ノート
読み込み中…